Since 1995 FDA scientists have been at odds against FDA managers who routinely override sientists’ safety concerns to approve dubious prescription drugs. Continue reading →
“Prescription drug therapy stands as one of the most significant perils to health resulting from human activity.” What’s the FDA doing to stem the tide of this preventable epidemic? Continue reading →
The decision to suspend the trial is viewed as highly questionable, raising disturbing questions about the role that marketing played–especially in light of the fact that Zytiga’s patent is due to expire in 2017.
The latest area of controversy focuses on the proposed revision of the definition "behavioral addiction disorder" extending the addiction diagnosis to include drug, alcohol and gambling. It is estimated that the change would expand the number of people labeled as "addicts" by 20 to 30 million who would be entitled to treatment and disability payments costing taxpayers many hundreds of millions of dollars. Continue reading →
At a minimum, the practice of responsible medicine requires that physicians who prescribe drugs whose known severe adverse side effects are likely to cause their patients irreversible harm, requires that those physicians follow monitoring guidelines to ensure their patients’ safety.
An urgent call for a debate about the ethics of data secrecy. Absent the humanitarian raison d’etre for enrolling in a clinical trial, no human being should be put at any–even minimal risk–without adequate compensation as a laborer and the protection of Workmen’s Compensation insurance.
A year after professor Susan M. Reverby, a historian at Wellesley College in Massachusetts, uncovered a heinous Guatemalan syphilis experiment conducted between 1946 and 1948, on at least 5,500 under the auspices of the US Public Health Service, a hearing was . . . Continue reading →
Three new studies–one,, a pharmaco-genetic study, is groundbreaking–confirm that widely prescribed psychotropic drugs that pose serious risks of harm, offer no therapeutic benefit.
Following our March 15 Infomail/ post, "Inside Psychiatry’s Battle to Define Mental Illness," we received an e-mail from Dr. Allen Frances, objecting–in essence retracting his statements in an article in WIRED magazine by Gary Greenverg. Our response to Dr. Frances follows his communication.
“The law says veterans have the right to due process.But when the fiduciary process is initiated, that all goes out the window.” Continue reading →
Before 2007, the research community had dogmatically insisted that only embryonic stem cell research would be medically useful, and that adult stem cell research was a waste of resources and effort. The contentious debate was framed as between “enlightened” scientists and religious . . . Continue reading →
Johnson & Johnson officilas made a business decision to decieve doctors by lying about the diabetes risk: “how much commercial liability would we incur if we sent a similar letter about Risperdal”? Continue reading →